‘Off-label’ drug use: an FDA regulatory term, not a negative implication of its medical use.
Autor: | Meadows, W. A.1, Hollowell, B. D.1 bhollowell@reminger.com |
---|---|
Zdroj: | International Journal of Impotence Research. Mar/Apr2008, Vol. 20 Issue 2, p135-144. 10p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |